Results are from another independent study. (What other rabbits...

Results are from another independent study. (What other rabbits does RECCE have in it's hat?)

Chief Scientific Officer, Michele Diliza, said, “While necrotizing fasciitis is a rare and extremely
challenging disease for physicians to manage, it is highly traumatising for patients and their families,
often leading to serious complications and even death. A broad spectrum anti-infective with rapid
efficacy has the potential to significantly change the treatment paradigm and save lives. We have been
thoroughly impressed with the efficacy that R327 has demonstrated thus far, as it reinforces our belief
in the potential of this compound against such aggressive, life-threatening bacteria.”